Autor: "Nguyen QD" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Management of repository corticotropin injection therapy for non-infectious uveitis: a Delphi study.
Autorzy:: Nguyen QD; Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA.
Anesi SD; Massachusetts Eye Research & Surgery Institution (MERSI), Waltham, MA, USA.
Chexal S; Retina Consultants of Austin, Austin, TX, USA.
Chu DS; Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, NJ, USA.; Metropolitan Eye Research and Surgery Institute, Palisades Park, NJ, USA.
Dayani PN; Retina-Vitreous Associates Medical Group, Los Angeles, CA, USA.
Leng T; Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA.
Meleth AD; Marietta Eye Clinic, Marietta, GA, USA.
Sallam AA; Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Sheppard JD; Virginia Eye Consultants, Norfolk, VA, USA.
Silverstein SM; University of Missouri Kansas City School of Medicine, Kansas City, MI, USA.
Toyos M; Toyos Clinic, Germantown, TN, USA.
Wang RC; Texas Retina Associates, Dallas, TX, USA.
Foster CS; Massachusetts Eye Research & Surgery Institution (MERSI), Waltham, MA, USA.; Pokaż więcej
Źródło:: Acta ophthalmologica [Acta Ophthalmol] 2021 Sep; Vol. 99 (6), pp. 669-678. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji:: Journal Article
MeSH Terms:: Consensus*
Delphi Technique*
Disease Management*
Adrenocorticotropic Hormone/*administration & dosage
Uveitis/*drug therapy
Adolescent ; Adult ; Child ; Female ; Hormones/administration & dosage ; Humans ; Injections ; Male ; Middle Aged ; Ophthalmologists ; Uveitis/diagnosis ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Systemic immunosuppressive therapies for uveitis in developing countries.
Autorzy:: Agrawal H; L V Prasad Eye Institute, Hyderabad, Telangana, India.
Doan H; Byers Eye Institute, Palo Alto, CA, USA.
Pham B; Byers Eye Institute, Palo Alto, CA, USA.
Khosla A; Sir Ganga Ram Hospital, New Delhi, India.
Babu M; Aravind Eye Institute, Salem, Tamil Nadu, India.
McCluskey P; Save Sight Institute, Sydney NSW, Australia, USA.
Nguyen QD; Byers Eye Institute, Palo Alto, CA, USA.
Sangwan V; Dr Shroff Charity Eye Hospital, New Delhi, India.
Reddy S; L V Prasad Eye Institute, Hyderabad, Telangana, India.
Sawhney S; Sir Ganga Ram Hospital, New Delhi, India.
Tyagi M; L V Prasad Eye Institute, Hyderabad, Telangana, India.; Pokaż więcej
Źródło:: Indian journal of ophthalmology [Indian J Ophthalmol] 2020 Sep; Vol. 68 (9), pp. 1852-1862.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Developing Countries*
Uveitis*/drug therapy
Adrenal Cortex Hormones ; Humans ; Immunosuppression Therapy ; Immunosuppressive Agents

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Evolving Consensus Experience of the IUSG-IOIS-FOIS with Uveitis in the Time of COVID-19 Infection.
Autorzy:: Zierhut M; Centre of Ophthalmology, University of Tuebingen , Tuebingen, Germany.
De Smet MD; MicroInvasive Ocular Surgery Clinic , Lausanne, Switzerland.; Department of Ophthalmology, University of Leiden , Leiden, The Netherlands.
Gupta V; Department of Ophthalmology, Advance Eye Centre, Post Graduate Institute of Medical Education and Research , Chandigarh, India.
Pavesio C; Department of Medical Retina and Uveitis, Moorfields Eye Hospital , London, UK.
Nguyen QD; Spencer Center for Vision Research, Byers Eye Institute, Stanford University , Palo Alto, California, USA.
Chee SP; Department of Ophthalmology, Singapore National Eye Centre , Singapore, Singapore.; Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore , Singapore, Singapore.; Department of Ophthalmology, Singapore Eye Research Institute , Singapore, Singapore.; Department of Ophthalmology & Visual Sciences Academic Clinical Program, Duke-NUS Medical School , Singapore, Singapore.
Cunningham ET; The Department of Ophthalmology, California Pacific Medical Center , San Francisco, California, USA.; The Department of Ophthalmology, Stanford University School of Medicine, Stanford, California , USA.; The Francis I. Proctor Foundation, UCSF School of Medicine, San Francisco, California , USA.; West Coast Retina Medical Group, San Francisco, California , USA.
Agrawal R; Department of Medical Retina and Uveitis, Moorfields Eye Hospital , London, UK.; Spencer Center for Vision Research, Byers Eye Institute, Stanford University , Palo Alto, California, USA.; Department of Ophthalmology, Singapore Eye Research Institute , Singapore, Singapore.; Department of Ophthalmology & Visual Sciences Academic Clinical Program, Duke-NUS Medical School , Singapore, Singapore.; Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital , Singapore, Singapore.; Pokaż więcej
Źródło:: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2020 Jul 03; Vol. 28 (5), pp. 709-713.
Typ publikacji:: Editorial
MeSH Terms:: Betacoronavirus*
Coronavirus Infections/*epidemiology
Ophthalmology/*organization & administration
Pneumonia, Viral/*epidemiology
Practice Guidelines as Topic/*standards
Practice Patterns, Physicians'/*standards
Uveitis/*diagnosis
Uveitis/*therapy
COVID-19 ; Consensus ; Coronavirus Infections/diagnosis ; Humans ; Internationality ; Pandemics ; Pneumonia, Viral/diagnosis ; Risk Factors ; SARS-CoV-2 ; Societies, Medical

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: New therapies in development for the management of non-infectious uveitis: A review.
Autorzy:: Hassan M; Byers Eye Institute, Stanford University, Palo Alto, California.
Karkhur S; Byers Eye Institute, Stanford University, Palo Alto, California.; Department of Ophthalmology, Sadguru Netra Chikitsalaya, Chitrakoot, India.
Bae JH; Byers Eye Institute, Stanford University, Palo Alto, California.; Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Halim MS; Byers Eye Institute, Stanford University, Palo Alto, California.
Ormaechea MS; Byers Eye Institute, Stanford University, Palo Alto, California.; Department of Ophthalmology, Hospital Universitario Austral, Buenos Aires, Argentina.
Onghanseng N; Byers Eye Institute, Stanford University, Palo Alto, California.
Nguyen NV; Byers Eye Institute, Stanford University, Palo Alto, California.
Afridi R; Byers Eye Institute, Stanford University, Palo Alto, California.
Sepah YJ; Byers Eye Institute, Stanford University, Palo Alto, California.
Do DV; Byers Eye Institute, Stanford University, Palo Alto, California.
Nguyen QD; Byers Eye Institute, Stanford University, Palo Alto, California.; Pokaż więcej
Źródło:: Clinical & experimental ophthalmology [Clin Exp Ophthalmol] 2019 Apr; Vol. 47 (3), pp. 396-417.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Uveitis/*drug therapy
Alkylating Agents/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antimetabolites, Antineoplastic/therapeutic use ; Glucocorticoids/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use ; Inflammation/prevention & control

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Adalimumab in Active and Inactive, Non-Infectious Uveitis: Global Results from the VISUAL I and VISUAL II Trials.
Autorzy:: Goto H; a Department of Ophthalmology , Tokyo Medical University , Tokyo , Japan.
Zako M; b Department of Ophthalmology , Asai Hospital , Aichi , Japan.
Namba K; c Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine , Hokkaido University , Sapporo , Japan.
Hashida N; d Department of Ophthalmology , Osaka University Graduate School of Medicine , Osaka , Japan.
Kaburaki T; e Department of Ophthalmology , The University of Tokyo Graduate School of Medicine , Tokyo , Japan.
Miyazaki M; f Department of Ophthalmology , Kyushu University Graduate School of Medicine , Fukuoka , Japan.
Sonoda KH; f Department of Ophthalmology , Kyushu University Graduate School of Medicine , Fukuoka , Japan.
Abe T; g Division of Clinical Cell Therapy , Tohoku University Graduate School of Medicine , Miyagi , Japan.
Mizuki N; h Department of Ophthalmology , Yokohama City University School of Medicine , Yokohama , Japan.
Kamoi K; i Department of Ophthalmology & Visual Science , Tokyo Medical and Dental University , Tokyo , Japan.
Brézin AP; j Centre d'ophtalmologie de l'Assistance Publique , Hôpitaux de Paris, Hôpital Cochin, Université Paris Descartes , Paris , France.
Dick AD; k University of Bristol, Bristol Eye Hospital, Bristol, United Kingdom, and National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital and University College London, Institute of Ophthalmology , London , UK .
Jaffe GJ; l Duke Eye Center , Duke University Hospital , Durham , North Carolina , USA.
Nguyen QD; m Department of Ophthalmology , Byers Eye Institute, Stanford University , Palo Alto , California , USA.
Inomata N; n AbbVie GK Japan , Tokyo , Japan.
Kwatra NV; o AbbVie Inc ., North Chicago , Illinois , USA.
Camez A; p AbbVie Deutschland GmbH & Co KG , Ludwigshafen , Germany.
Song AP; o AbbVie Inc ., North Chicago , Illinois , USA.
Kron M; p AbbVie Deutschland GmbH & Co KG , Ludwigshafen , Germany.
Tari S; o AbbVie Inc ., North Chicago , Illinois , USA.
Ohno S; c Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine , Hokkaido University , Sapporo , Japan.; Pokaż więcej
Źródło:: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2019; Vol. 27 (1), pp. 40-50. Date of Electronic Publication: 2018 Jul 17.
Typ publikacji:: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:: Adalimumab/*therapeutic use
Anti-Inflammatory Agents/*therapeutic use
Uveitis/*drug therapy
Adult ; Double-Blind Method ; Endpoint Determination ; Female ; Humans ; Japan ; Male ; Middle Aged ; Treatment Outcome ; Uveitis/physiopathology ; Visual Acuity/physiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends.
Autorzy:: Agarwal A; a Advanced Eye Centre , Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.
Agrawal R; b National Healthcare Group Eye Institute , Tan Tock Seng Hospital , Singapore, Singapore.; c Moorfields Eye Hospital , NHS Foundation Trust , London , UK.; d Department of Ophthalmology , Yong Loo Lin School of Medicine, National University of Singapore , Singapore.; e Singapore Eye Research Institute , Singapore , Singapore.
Gunasekaran DV; b National Healthcare Group Eye Institute , Tan Tock Seng Hospital , Singapore, Singapore.; c Moorfields Eye Hospital , NHS Foundation Trust , London , UK.; d Department of Ophthalmology , Yong Loo Lin School of Medicine, National University of Singapore , Singapore.
Raje D; f CSTAT , Royal Statistician Society , London, UK.
Gupta B; g Royal Berkshire Hospital , NHS Foundation Trust , Reading , UK.
Aggarwal K; a Advanced Eye Centre , Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.
Murthy SL; h Tej Kohli Cornea Institute, LV Prasad Eye Institute , Kallam Anji Reddy Campus , Hyderabad , India.
Westcott M; c Moorfields Eye Hospital , NHS Foundation Trust , London , UK.
Chee SP; d Department of Ophthalmology , Yong Loo Lin School of Medicine, National University of Singapore , Singapore.; e Singapore Eye Research Institute , Singapore , Singapore.; i Singapore National Eye Centre , Singapore, Singapore.; j Duke-NUS Medical School , Singapore , Singapore.
McCluskey P; k Department of Clinical Ophthalmology & Eye Health , Central Clinical School, Save Sight Institute, The University of Sydney , Sydney , Australia.
Ling HS; b National Healthcare Group Eye Institute , Tan Tock Seng Hospital , Singapore, Singapore.
Teoh S; b National Healthcare Group Eye Institute , Tan Tock Seng Hospital , Singapore, Singapore.
Cimino L; l Ocular Immunology Unit, Department of Ophthalmology Arcispedale-IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia , Italy.
Biswas J; m Sankara Nethralaya , Chennai , India.
Narain S; n Shroff Eye Centre , New Delhi , India.
Agarwal M; o Dr Shroff's Charity Eye Hospital Daryaganj , New Delhi , India.
Mahendradas P; p Narayana Nethralaya , Bangalore , India.
Khairallah M; q Department of Ophthalmology, Fattouma Bourguiba University Hospital, Faculty of Medicine, University of Monastir, Monastir , Tunisia.
Jones N; r University of Manchester , UK.
Tugal-Tutkun I; s Istanbul Faculty ofMedicine, Department of Ophthalmology , Istanbul University , Istanbul , Turkey.
Babu K; t Department of Ophthalmology, Prabha Eye Clinic & Research centre , Vittala International Institute of Ophthalmology , Bangalore , India.
Basu S; u LV Prasad Eye Institute , Bhubaneswar , India.
Carreño E; v Bristol Eye Hospital , UK.
Lee R; v Bristol Eye Hospital , UK.
Al-Dhibi H; w King Khaled Eye Specialist Hospital , Riyadh , Kingdom of Saudi Arabia.
Bodaghi B; x DHU SightRestore , University of Pierre andMarie Curie , Paris , France.
Invernizzi A; y Eye Clinic, Department of Biomedical and Clinical Science 'L. Sacco' , Luigi Sacco Hospital, University of Milan , Milan , Italy.
Goldstein DA; z Feinberg School of Medicine, Department of Ophthalmology , Northwestern University , Chicago , Illinois , USA.
Herbort CP; aa Centre for Ophthalmic Specialised Care & University of Lausanne , Lausanne , Switzerland.
Barisani-Asenbauer T; ab Laura Bassi Centre of Expertise Ocuvac, Center for Pathophysiology, Immunology and Infectiology , Medical University of Vienna , Vienna , Austria.
González-López JJ; ac Ramón y Cajal University Hospital, IRYCIS, Universidad de Alcala , Spain.
Androudi S; ad Department of Ophthalmology , University of Thessaly , Volos , Greece.
Bansal R; a Advanced Eye Centre , Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.
Moharana B; a Advanced Eye Centre , Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.
Mahajan S; a Advanced Eye Centre , Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.
Esposti S; c Moorfields Eye Hospital , NHS Foundation Trust , London , UK.
Tasiopoulou A; c Moorfields Eye Hospital , NHS Foundation Trust , London , UK.
Nadarajah S; c Moorfields Eye Hospital , NHS Foundation Trust , London , UK.
Agarwal M; m Sankara Nethralaya , Chennai , India.
Abraham S; m Sankara Nethralaya , Chennai , India.
Vala R; p Narayana Nethralaya , Bangalore , India.
Singh R; a Advanced Eye Centre , Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.
Sharma A; ae Department of Rheumatology , PGIMER , Chandigarh, India.
Sharma K; af Department ofMicrobiology , PGIMER , Chandigarh, India.
Zierhut M; ag Centre of Ophthalmology, University of Tuebingen , Tuebingen , Germany.
Kon OM; ah Chest and Allergy Clinic, St Mary's Hospital , Imperial College HealthcareNHS Trust , London , UK.
Cunningham E; ai Francis I. Proctor Foundation for Research in Ophthalmology , University of California , San Francisco , USA.
Nguyen QD; aj Byers Eye Institute , Stanford University , Palo Alto , CA , USA.
Pavesio C; c Moorfields Eye Hospital , NHS Foundation Trust , London , UK.
Gupta V; a Advanced Eye Centre , Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.; Pokaż więcej
Źródło:: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2019; Vol. 27 (3), pp. 465-473. Date of Electronic Publication: 2017 Dec 20.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Antitubercular Agents/*therapeutic use
Eye Infections, Bacterial/*diagnosis
Mycobacterium tuberculosis/*genetics
Polymerase Chain Reaction/*methods
Tuberculosis, Ocular/*diagnosis
Uveitis/*diagnosis
Uveitis/*drug therapy
Adolescent ; Adult ; Aged ; Aqueous Humor/microbiology ; Child ; DNA, Bacterial/analysis ; Eye Infections, Bacterial/drug therapy ; Eye Infections, Bacterial/microbiology ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Mycobacterium tuberculosis/isolation & purification ; Retrospective Studies ; Tuberculosis, Ocular/drug therapy ; Tuberculosis, Ocular/microbiology ; Uveitis/microbiology ; Young Adult